MRK- their HEP C drug was approved by the FDA this afternoon after the market closed. The pricing for the drug is $54,600 for the 12 week regimen. GILD's HEP C drug costs $80,000 per patient
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.